Hua Medicine Releases Interim Report 2026 Online and Outlines Shareholder Communication Options

Bulletin Express

Sep 24

Hua Medicine (Hua Medicine-B) announced that its Interim Report 2026 is now accessible in both English and Chinese on the company’s website (www.huamedicine.com) and on the Hong Kong Stock Exchange’s website (www.hkexnews.hk).

Key points

• Access method: The company “strongly recommends” shareholders review the online version of the Interim Report 2026 and all future corporate materials. • Printed copies: Registered shareholders who cannot access the digital documents may request free printed copies by completing and returning the enclosed reply form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via prepaid mail or email (2552-ecom@vistra.com). • Email registration: Shareholders are responsible for providing and maintaining a functional email address. Without one on file, the company will dispatch physical notices and actionable corporate communications until a valid address is supplied. • Validity period: A preference for printed materials expressed via the reply form remains effective for all corporate communications until 31 December 2028 unless shareholders instruct otherwise. • Enquiries: Tricor’s hotline (+852 2980 1333) operates Monday to Friday, 09:00–18:00 (excluding public holidays), for related questions.

The notification was signed by Chief Executive Officer and Executive Director Dr. Li Chen on 24 September 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1186812970"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186812970\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186812970?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-24 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186812970","market":"hk","top_or_hot":-1,"title":"Hua Medicine Releases Interim Report 2026 Online and Outlines Shareholder Communication Options","media":"Bulletin Express","content":"<p>Hua Medicine (Hua Medicine-B) announced that its Interim Report 2026 is now accessible in both English and Chinese on the company’s website (www.huamedicine.com) and on the Hong Kong Stock Exchange’s website (www.hkexnews.hk).</p>\n<p>Key points</p>\n<p>• Access method: The company “strongly recommends” shareholders review the online version of the Interim Report 2026 and all future corporate materials.  \n• Printed copies: Registered shareholders who cannot access the digital documents may request free printed copies by completing and returning the enclosed reply form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via prepaid mail or email (2552-ecom@vistra.com).  \n• Email registration: Shareholders are responsible for providing and maintaining a functional email address. Without one on file, the company will dispatch physical notices and actionable corporate communications until a valid address is supplied.  \n• Validity period: A preference for printed materials expressed via the reply form remains effective for all corporate communications until 31 December 2028 unless shareholders instruct otherwise.  \n• Enquiries: Tricor’s hotline (+852 2980 1333) operates Monday to Friday, 09:00–18:00 (excluding public holidays), for related questions.</p>\n<p>The notification was signed by Chief Executive Officer and Executive Director Dr. Li Chen on 24 September 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hua Medicine Releases Interim Report 2026 Online and Outlines Shareholder Communication Options</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHua Medicine Releases Interim Report 2026 Online and Outlines Shareholder Communication Options\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-24 21:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hua Medicine (Hua Medicine-B) announced that its Interim Report 2026 is now accessible in both English and Chinese on the company’s website (www.huamedicine.com) and on the Hong Kong Stock Exchange’s website (www.hkexnews.hk).</p>\n<p>Key points</p>\n<p>• Access method: The company “strongly recommends” shareholders review the online version of the Interim Report 2026 and all future corporate materials.  \n• Printed copies: Registered shareholders who cannot access the digital documents may request free printed copies by completing and returning the enclosed reply form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via prepaid mail or email (2552-ecom@vistra.com).  \n• Email registration: Shareholders are responsible for providing and maintaining a functional email address. Without one on file, the company will dispatch physical notices and actionable corporate communications until a valid address is supplied.  \n• Validity period: A preference for printed materials expressed via the reply form remains effective for all corporate communications until 31 December 2028 unless shareholders instruct otherwise.  \n• Enquiries: Tricor’s hotline (+852 2980 1333) operates Monday to Friday, 09:00–18:00 (excluding public holidays), for related questions.</p>\n<p>The notification was signed by Chief Executive Officer and Executive Director Dr. Li Chen on 24 September 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02552","symbol_name":"华领医药-B","start_time":0,"source_url":"","article_id":"1186812970","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186812970","pubTimestamp":1790257395,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hua Medicine (Hua Medicine-B) announced that its Interim Report 2026 is now accessible in both English and Chinese on the company’s website (www.huamedicine.com) and on the Hong Kong Stock Exchange’s...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02552":"华领医药-B"},"translate_title":"华医药在线发布2026年中期报告并概述股东沟通选项","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02552":1},"content_text":"Hua Medicine (Hua Medicine-B) announced that its Interim Report 2026 is now accessible in both English and Chinese on the company’s website (www.huamedicine.com) and on the Hong Kong Stock Exchange’s website (www.hkexnews.hk).\nKey points\n• Access method: The company “strongly recommends” shareholders review the online version of the Interim Report 2026 and all future corporate materials.  \n• Printed copies: Registered shareholders who cannot access the digital documents may request free printed copies by completing and returning the enclosed reply form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via prepaid mail or email (2552-ecom@vistra.com).  \n• Email registration: Shareholders are responsible for providing and maintaining a functional email address. Without one on file, the company will dispatch physical notices and actionable corporate communications until a valid address is supplied.  \n• Validity period: A preference for printed materials expressed via the reply form remains effective for all corporate communications until 31 December 2028 unless shareholders instruct otherwise.  \n• Enquiries: Tricor’s hotline (+852 2980 1333) operates Monday to Friday, 09:00–18:00 (excluding public holidays), for related questions.\nThe notification was signed by Chief Executive Officer and Executive Director Dr. Li Chen on 24 September 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}